Latest Breaking News On - Debanjan ray - Page 1 : comparemela.com

Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies

Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Debanjan-ray
K-christopher-garcia
John-bertin
Howard-hughes-medical-institute
Merck-co
Stanford-university-school-of-medicine
Regeneron-pharmaceuticals
Getty-images
Menlo-park
Stanford-university-school

Normunity appoints industry leader Debanjan Ray to Board of Directors

BOSTON & WEST HAVEN, Conn. (BUSINESS WIRE) Normunity, Inc., a biotechnology company creating novel precision anti-cancer immunotherapies, today announced the appointment of Debanjan Ray, MBA, to its board of directors. Mr. Ray currently serves as President and Chief Executive Officer of Synthekine, and he has serv.

Boston
Massachusetts
United-states
Massachusetts-institute-of-technology
Rachel-humphrey
Debanjan-ray
Normunity-inc
Amgen
University-of-pennsylvania
Mckinsey-company
Linkedin
Portola-pharmaceuticals

Synthekine, Merck partner to develop new cytokine-based therapies

Synthekine, Merck partner to develop new cytokine-based therapies
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Debanjan-ray
Merck-research-laboratories
Research-laboratories

Stanford spinout Synthekine raises $107.5M on promise of new way to attack cancer, autoimmune diseases

Stanford spinout Synthekine raises $107.5M on promise of new way to attack cancer, autoimmune diseases
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

Stanford
California
United-states
Menlo-park
Massachusetts
Stanford-university
Rock-springs
Ireland
Deerfield
San-francisco
Chris-garcia
Ron-leuty

Synthekine Strengthens Leadership with Board of Directors Expansion and Scientific Advisory Board Formation

Published: Feb 04, 2021 MENLO PARK, Calif. (BUSINESS WIRE) Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has appointed Pablo Cagnoni, M.D., to its board of directors. Dr. Cagnoni brings to Synthekine extensive leadership experience in the biotech industry and a successful track record of oncology drug development. The company also announced the formation of its scientific advisory board to help guide the company’s extensive cytokine engineering efforts. “Synthekine has made significant advances in 2020, with our first programs on track for IND filings in 2021, and I am delighted to have Pablo join our board of directors and bring his considerable insights in developing breakthrough oncology products to support our continued progress,” said Debanjan Ray, CEO of Synthekine. “At the same time, our distinguished scientific advisory board will provide guidance as we apply our multiple cytokine engineering efforts to importan

University-of-pennsylvania
Pennsylvania
United-states
Christophera-hunter
E-john-wherry
Debanjan-ray
Pablo-cagnoni
K-christopher-garcia
Nils-lonberg
Amgen
Allos-therapeutics
University-of-pennsylvania-institute-for-immunology